Douglas (Shifang) Zhang

Zhang Shifang

Lanyard Therapeutics

2015-2016

Affiliations

Columbia University

Technologies

Therapeutic

Indication

Oncology

Executive Summary

View/Download

We are developing a First-in-class and Best-in-class Biologics for Mechanism-based Cancer Immunotherapy

Newsletter Signup

Corporate Supporters

Community Service Providers